Lemonade, Inc. (NYSE:LMND – Get Free Report) insider Maya Prosor sold 30,000 shares of Lemonade stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $50.00, for a total value of $1,500,000.00. Following the transaction, the insider now owns 29,286 shares in the company, valued at approximately $1,464,300. This represents a 50.60 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Maya Prosor also recently made the following trade(s):
- On Monday, November 11th, Maya Prosor sold 20,000 shares of Lemonade stock. The stock was sold at an average price of $30.00, for a total transaction of $600,000.00.
Lemonade Stock Up 3.5 %
NYSE LMND traded up $1.73 during trading on Monday, hitting $51.01. The stock had a trading volume of 3,917,903 shares, compared to its average volume of 1,778,735. The firm has a 50 day moving average price of $22.98 and a 200 day moving average price of $19.54. Lemonade, Inc. has a twelve month low of $14.03 and a twelve month high of $53.85. The company has a market capitalization of $3.64 billion, a PE ratio of -17.43 and a beta of 1.68.
Hedge Funds Weigh In On Lemonade
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Blue Trust Inc. lifted its stake in Lemonade by 220.0% in the third quarter. Blue Trust Inc. now owns 2,733 shares of the company’s stock worth $45,000 after acquiring an additional 1,879 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. raised its holdings in shares of Lemonade by 321.3% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,462 shares of the company’s stock valued at $74,000 after purchasing an additional 3,403 shares in the last quarter. Quest Partners LLC lifted its position in shares of Lemonade by 1,647.6% during the 3rd quarter. Quest Partners LLC now owns 9,105 shares of the company’s stock worth $150,000 after purchasing an additional 8,584 shares during the last quarter. Concurrent Investment Advisors LLC acquired a new position in shares of Lemonade during the second quarter worth $180,000. Finally, Bristlecone Advisors LLC purchased a new position in Lemonade in the third quarter valued at $218,000. Hedge funds and other institutional investors own 80.30% of the company’s stock.
Analyst Ratings Changes
LMND has been the topic of a number of recent analyst reports. Piper Sandler upped their price objective on Lemonade from $25.00 to $44.00 and gave the company a “neutral” rating in a report on Thursday. Jefferies Financial Group cut their price objective on Lemonade from $15.00 to $14.00 and set an “underperform” rating for the company in a research report on Wednesday, October 9th. JMP Securities boosted their price objective on shares of Lemonade from $40.00 to $60.00 and gave the company a “market outperform” rating in a report on Friday. BMO Capital Markets increased their target price on shares of Lemonade from $13.00 to $15.00 and gave the stock an “underperform” rating in a research note on Thursday. Finally, Keefe, Bruyette & Woods cut shares of Lemonade from a “market perform” rating to an “underperform” rating and lifted their price target for the company from $18.00 to $21.00 in a research report on Thursday, November 7th. Three analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $30.43.
Check Out Our Latest Stock Report on Lemonade
Lemonade Company Profile
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Further Reading
- Five stocks we like better than Lemonade
- Which Wall Street Analysts are the Most Accurate?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What Are the FAANG Stocks and Are They Good Investments?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.